Delivery Order SPE2DB20D7066-SPE2DB25FC4QH
Award Date 9/5/25
Potential Completion Date 9/8/25
Potential Value $54K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $54,368.42 to AmerisourceBergen Drug Corp for the supply of IPOL vial 5ML, a poliomyelitis vaccine product. This firm fixed price, competitively awarded delivery order was issued on September 2, 2025, with an ultimate completion date of September 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $2,180.20 to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Ipol Vial 5ML, a polio vaccine product. This is a firm fixed price, non-competitive delivery order with a completion date of May 28, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child contract action, this delivery order is issued under a larger vehicle—AmerisourceBergen's Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Ipol Vial 5ML, a poliomyelitis vaccine product. This firm fixed price delivery order has a ceiling value of $31,302.96 and an ultimate completion date of August 22, 2025, with no set-aside designation. The contract represents a non-competitive award made under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,090.10 to AmerisourceBergen Drug Corp for a 5mL vial of Ipol (polio vaccine) on July 22, 2025, with an ultimate completion date of July 23, 2025. This delivery order was competitively awarded with firm fixed pricing and no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. This delivery order is a child contract issued...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $36,690.60 by the Defense Logistics Agency for the supply of Ipol vial 5ml on April 24, 2025, with an ultimate completion date of April 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken facility. Ipol is an inactivated polio vaccine used within...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $2,094.49 for IPOL vials (5mL) on July 15, 2025, with completion expected by July 16, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,307.21 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Ipol Vial 5ML, a polio vaccine product. This firm fixed-price, non-set-aside contract is scheduled for completion by August 20, 2025, with performance at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a pediatric immunization pharmaceutical requirement within the federal medical supply chain. This award is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of IPOL Vial 5ML, a poliomyelitis vaccine product. This firm fixed-price delivery order, valued at $1,526.14, represents a non-competitive award and is categorized as a child contract under AmerisourceBergen's larger federal contract vehicle. The order is scheduled for completion by August 19, 2025, with performance at the contractor's location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $17,441.60 to AmerisourceBergen Drug Corp for IPOL Vial 5ML, an inactivated polio vaccine product. Issued on April 24, 2025, with completion scheduled for April 25, 2025, this firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $38,677.88 to AmerisourceBergen Drug Corp for the supply of IPOL Vial 5ML pharmaceutical products. This firm fixed-price, competitively awarded delivery order was issued on July 23, 2025, with an ultimate completion date of July 24, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating AmerisourceBergen Drug Corp...